Department of Surgery-Colon and Rectal Surgery, Ascension Providence Hospital, Southfield, MI 48075, United States.
Department of Surgery-Colon and Rectal Surgery, Ascension Providence Hospital, Michigan State University College of Human Medicine, Southfield, MI 48075, United States.
World J Gastroenterol. 2024 Nov 28;30(44):4745-4753. doi: 10.3748/wjg.v30.i44.4745.
This article discusses the literature review article by Pacheco published in July 2024; the authors provided good reviews of perianal Crohn's disease (CD), and challenges faced by clinicians in the management. CD, characterized by its chronic and relapsing nature, is an idiopathic condition that can involve any segment of the gastrointestinal tract. Perianal disease impacts up to 40% of patients with CD, with perianal fistulas constituting up to 80% of perianal lesions. Perianal CD can be highly incapacitating and profoundly diminish the overall well-being of patients. The management focuses on controlling the perianal sepsis and treating luminal CD. Biologics are crucial to the treatment approach, and results have been encouraging. The surgery focuses on controlling the sepsis, with more definitive treatments being fistula surgery, fecal diversion, and proctectomy as the last resort. This manuscript briefly describes the burden of CD, the challenges posed by perianal CD, and the role of different treatment modalities from colorectal surgeon's perspective.
这篇文章讨论了 Pacheco 于 2024 年 7 月发表的文献综述文章;作者对肛周克罗恩病 (CD) 进行了很好的回顾,并讨论了临床医生在管理中面临的挑战。CD 以其慢性和复发性为特征,是一种特发性疾病,可累及胃肠道的任何部位。肛周疾病影响多达 40%的 CD 患者,其中肛周瘘管构成多达 80%的肛周病变。肛周 CD 可严重致残,并严重降低患者的整体健康水平。管理的重点是控制肛周脓肿并治疗肠道 CD。生物制剂是治疗方法的关键,且已取得令人鼓舞的结果。手术的重点是控制脓肿,更确定性的治疗方法是瘘管手术、粪便分流和直肠切除术作为最后的手段。本文简要描述了 CD 的负担、肛周 CD 带来的挑战以及从结直肠外科医生的角度来看不同治疗方式的作用。